Polycythemia vera (PV)
- Keep hematocrit <45%
- Phlebotomy + low-dose aspirin for most
- Cytoreduce higher-risk disease
- hydroxyurea or interferon common
- JAK inhibitor for selected resistant/intolerant disease
- Manage thrombosis risk aggressively
Use at a glance
Practical pearls
- Phlebotomy + low-dose aspirin for most
Choosing treatment
- JAK inhibitor for selected resistant/intolerant disease
Other practical pearls
- Cytoreduce higher-risk disease
- hydroxyurea or interferon common
- Manage thrombosis risk aggressively
Self-check
- What hematocrit target is used in Polycythemia vera (PV)?
<45%
Drugs used for this (2)
All clinical uses · Open the interactive console ↗
